Trials / Unknown
UnknownNCT01041183
The Effect of Oral and Intravenous Ramosetron During Laparoscopic Cholecystectomy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Patients undergoing general anesthesia for laparoscopic cholecystectomy have a high risk of postoperative nausea and vomiting (PONV). The investigators investigated the effect of oral and IV ramosetron on PONV prophylaxis after laparoscopic cholecystectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intravenous ramosetron | 0.3 mg IV ramosetron (group I) |
| DRUG | oral ramosetron | 0.1 mg oral ramosetron (group II) |
| DRUG | oral and IV ramosetron | 0.1 mg oral ramosetron plus 0.3 mg IV ramosetron (group III). |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2009-12-01
- First posted
- 2009-12-31
- Last updated
- 2009-12-31
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01041183. Inclusion in this directory is not an endorsement.